Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes

Journal of Neurochemistry

Volumn 84, Issue 6, 2003, Pages 1378-1386

  Lu, Lin ^a,b,c   Liu, Zhiyuan ^a   Huang, Mingsheng ^a   Zhang, Zhangying ^b,d  

^a SICHUAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Behavioral response; Cocaine reward; Corticotropin releasing factor antagonist; Dopamine; Nucleus accumbens; Ventral tegmental area

Indexed keywords

AS 30; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; COCAINE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR SUBTYPE 1 ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR SUBTYPE 2 ANTAGONIST; DOPAMINE; RECEPTOR SUBTYPE; SAUGUVINE 30 ANTIBODY; UNCLASSIFIED DRUG;

ALPHA HELIX; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; COCAINE DEPENDENCE; CONTROLLED STUDY; DOPAMINE RELEASE; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; TRAINING; VENTRAL TEGMENTUM;

ANIMALS; BEHAVIOR, ANIMAL; COCAINE; CORTICOTROPIN-RELEASING HORMONE; DOPAMINE; EXTRACELLULAR SPACE; HORMONE ANTAGONISTS; MALE; MICRODIALYSIS; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PEPTIDE FRAGMENTS; PYRIMIDINES; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SPATIAL BEHAVIOR; VENTRAL TEGMENTAL AREA;

ANIMALIA;

EID: 0037345745     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01635.x     Document Type: Article

References (60)

1. Basso A. M., Spina M., Rivier J., Vale W. and Koob G. F. (1999) Corticotropin-releasing factor antagonist attenuates the 'anxiogenic-like' effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology 145, 21-30.
2. Cador M., Bjijou Y. and Stinus L. (1995) Evidence of a complete in dependence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience 65, 385-395.
3. Chalmers D. T., lovenberg T. W. and De Souza E. B. (1995) Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: Comparison with CRF1 receptor mRNA expression. J. Neurosci. 15, 6340-6350.
4. Coste S. C., Kesterson R. A., Heldwein K. A. et al. (2000) Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat. Genet. 24, 403-409.
5. De Souza E. B. (1995) Corticortropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 20, 789-819.
6. Donaldson C. J., Sutton S. W., Perrin M. H., Corrigan A. Z., Lewis K. A., Rivier J., Vaughan J. M. and Vale W. W. (1996) Cloning and characterization of human urocortin. Endocrinology 137, 2167- 2170.
7. Erb S., Shaham Y. and Stewart J. (1998) The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J. Neurosci. 18, 5529-5536.
8. Goeders N. E. (2002) The HPA axis and cocaine reinforcement. Psychoneuroendocrinology 27, 13-33.
9. Grigoriadis D. E., Lovenberg T. W. and De Souza E. B. (1996) Characterization of corticotropin-releasing factor receptor subtypes. Ann. NY Acad. Sci. 780, 60-80.
10. Habib K. E., Weld K. P., Rice K. C. et al. (2000) Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc. Natl Acad. Sci. USA 97, 6079-6084.
11. Heinrichs S. C., Menzaghi F., Schulteis G. F., Koob G. F. and Stinus L. (1995) Suppression of corticotropin releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav. Pharmacol. 6, 74-80.
12. Heinrichs S. C., Stenzel-Poore M. P., Gold L. H., Battenberg E., Bloom F. E., Koob G. F., Vale W. W. and Pich E. M. (1996) Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor. Neuroscience 74, 303-311.
13. Holsboer F. (1999) The rationale for corticotropin-releasing hormone receptor (CRH-R.) antagonists to treat depression and anxiety. J. Psychiat. Res. 33, 181-214.
14. Holsboer F. and Barden N. (1996) Antidepressants and hypothalamic-adrenocortical regulation. Endocrine Rev. 17, 181-205.
15. Iredale P. A., Alvaro J. D., Lee Y., Terwilliger R., Chen Y. L. and Duman R. S. (2000) Role of corticotropin-releasing factor receptor-1 in opiate withdrawal. J. Neurochem. 74, 199-208.
16. Kalivas P. W. and Nakamura M. (1999) Neural systems for behavioral activation and reward. Curr. Opin. Neurobiol. 9, 223-227.
17. Kishimoto T, Radulovic J., Radulovic M., Lin C. R., Schrick C., Hooshmand F., Hermanson O., Rosenfeld M. G. and Spiess J. (2000) Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat. Genet. 24, 415-419.
18. Koob G. F. and Heinrichs S. C. (1999) A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res. 848, 141-152.
19. Koob G. F., Heinrichs S. C., Menzaghi F., Merlo-Pich E. and Britton K. T. (1994) Corticotropin-releasing factor, stress and behavior. Semin. Neurosci. 6, 221-229.
20. Kreek M. J., Ragunath J., Plevy S., Hamer D., Schneider B. and Hartman N. (1984) ACTH, cortisol and beta-endorphin response to metyrapone testing during chronic methadone maintenance treatment in humans. Neuropeptides 5, 277-278.
21. Le A. D., Harding S., Juzytsch W., Watchus J., Shalev U. and Shaham Y. (2000) The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology 150, 317-324.
22. Liebsch G., Landgraf R., Engelmann M., Lorscher P. and Holsboer F. (1999) Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain. J. Psychiatr. Res. 33, 153-163.
23. Lovenberg T. W., Liaw C. W., Grigoriadis D. E., Clevenger W., Chalmers D. T., De Souza E. B. and Oltersdorf T. (1995) Cloning and charaterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl Acad. Sci. USA 92, 836-840.
24. Lu L., Ceng X. and Huang M. (2000a) Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to opiate dependence in rats. Neuroreport 11, 2373-2378.
25. Lu L., Liu D., Ceng X. and Ma L. (2000b) Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence. Eur. J. Neurosci. 12, 4398-4404.
26. Lu L., Liu D. and Ceng X. (2001) Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats. Eur. J. Pharmacol. 415, 203-208.
27. Lu L., Zhang B., Liu Z. and Zhang Z. (2002) Reactivation of cocaine conditioned place preference induced by stress is reversed by cholecystokinin-B receptors antagonist in rats. Brain Res. 954, 132-140.
28. Maldonado R., Saiardi A., Valverde O., Samad T. A., Roques B. P. and Borrelli E. (1997) Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388, 586-589.
29. Mansi J. A., Rivest S. and Drolet G. (1996) Regulation of corticotropin-releasing factor type 1 (CRF 1) receptor messenger ribonucleis acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF. Endocrinology 137, 4619-4629.
30. Menzaghi F., Rassnick S., Heinrichs S., Baldwin H., Pich E. M., Weiss F. and Koob G. F. (1994) The role of corticotropin-releasing factor in the anxiogenic effects of ethanol withdrawal. Ann. NY Acad. Sci. 739, 176-184.
31. Paulson P. E. and Robinson T. E. (1991) Sensitization to systemic amphetamine produces an enhanced locomotor response to a subsequent intra-accumbens amphetamine challenge in rats. Psychopharmacology 104, 140-141.
32. Paxinos G. and Watson C. (1997) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.
33. Perrin M. H., Donaldson C. J., Chen R., Lewis K. A. and Vale W. W. (1993) Cloning and functional expression of a rat brain corticotropin-releasing factor (CRF) receptor. Endocrinology 133, 3058-3061.
34. Piazza P. V. and Le Moal M. (1997) Glucocorticoids as a biological substrate of reward: physiological and pathphysiological implications. Brain Res. Rev. 25, 359-372.
35. Pierce R. C. and Kalivas P. W. (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain. Res. Rev. 25, 192-216.
36. Pierce R. C., Pierce-Bancroft A. F. and Prasad B. M. (1999) Neurotrophin-3 contributes to the inhibition of behavioral sensitization to cocaine by activating the ras/mitogen-activated protein kinase signal transduction cascade. J. Neurosci. 19, 8685-8695.
37. Pozzoli G., Bilezikjian L. M., Perrin M. H., Blount A. L. and Vale W. W. (1996) Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures. Endocrinology 137, 65-71.
38. Primus R. J., Yevich E., Baltazar C. and Gallager D. W. (1997) Autoradiographic localization of CRF 1 and CRF2 binding sites in adult rat brain. Neuropsychopharmacology 17, 308-316.
39. Radulovic J., Ruhmann A., Liepold T. and Spiess J. (1999) Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential role of CRF receptors 1 and 2. J. Neurosci. 19, 5616-5025.
40. Richter R. M. and Weiss F. (2000) In vive CRF release in rat amygdala is increased during cocaine withdrawal in self-administration rats. Synapse 32, 254-261.
41. Robinson T. E. and Berridge K. C. (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18, 247-291.
42. Rodriguez de Fonseca F. R., Carrera M. R. A., Navarro M., Koob G. F. and Weiss F. (1997) Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276, 2050-2054.
43. Ruhmann A., Bonk I., Lin C. R., Rosenfeld M. G. and Spiess J. (1998) Structural requirements for pepridic antagonists of the corlicotropin-releasing factor receptor (CRFR): development of CRFR2β selective antisauvagine-30. Proc. Natl J. Acad. Sci. USA 95, 15 264-15 269.
44. Samyai Z., Biro E., Gardi J., Vecsemyes M., Julesz J. and Telegdy G. (1995) Brain corticotropin-releasing factor mediates anxiety-like behavior induced by cocaine withdrawal in rats. Brain Res. 675, 89-97.
45. Samyai Z., Shaham Y. and Heinrichs S. C. (2001) The role of corticotropin-releasing factor in drug addiction. Pharmacoil. Rev. 53, 209-243.
46. Service R. F. (1999) Probing alcoholism's 'dark side'. Science 285, 1473-1474.
47. Shaham Y., Funk D., Erb S., Brown T. J., Walker C. D. and Stewart J. (1997) Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin seeking in rats. J. Neurosci. 17, 2605-2614.
48. Shaham Y., Erb S., Leung S., Buczek Y. and Stewart J. (1998) CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Psychopharmarmacology 137, 184-190.
49. Shibasaki T., Yamauchi N., Hotta M., Imaki T., Oda T., Ling N. and Demura H. (1991) Brain corticotropin-releasing hormone increases arousal in stress. Brain Res. 554, 352-354.
50. Steckler T. and Holsboer F. (1999) Corticotropin-releasing hormone receptor subtypes and emotion. Biol. Psychiat. 46, 1480-1508.
51. Stewart J. (1984) Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area. Pharmacol. Biochem. Behav. 20, 917-923.
52. Stewart J. (2000) Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug taking. J. Psychiat. Neurosci. 25, 125-136.
53. Takahashi L. K. (2001) Role of CRF (1) and CRF (2) receptors in fear and anxiety. Neurosci. Biobehav. Rev. 25, 627-636.
54. Takahashi L. K., Ho S. P., Livanov V., Graciani N. and Americ S. P. (2001) Antagonism of CRF (2) receptors produces anxiolytic behavior in animal models of anxiety. Brain Res. 902, 135-142.
55. Tzschentke T. M. (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56, 613-672.
56. Vale W., Spiess J. and Rivier J. (1981) Characterization of a 41 -residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213, 1394-1397.
57. Wise R. A. and Bozarth M. A. (1987) A psychomotor stimulant theory of addiction. Psychol. Rev. 94, 469-492.
58. Wolf M. E. (1998) The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54, 679-720.
59. Zhou Y., Spangler R., Laforge K. S., Maggos C. E., Ho A. and Kreek M. J. (1996) Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during binge-pattern cocaine administration and chronic withdrawal. J. Pharmacol. Exp. Ther. 279, 351-358.
60. Zobel A. W., Nickel T., Kunzel H. E., Ackl N., Sonntag A., Ising M. and Holsboer F. (2000) Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J. Psychiat. Res. 34, 171-181.